Home  |  Archive  |  Online Submission  |  News & Events  |  Subscribe  |  APFA  |  Society  |  Links  |  Contact Us  |  中文版

Ahead of print
Authors' Accepted
Current Issue
Special Issues
Browse by Category

Manuscript Submission

Online Submission
Online Review
Instruction for Authors
Instruction for Reviewers
English Corner new!

About AJA

About AJA
Editorial Board
Contact Us

Resources & Services

Email alert

Download area

Copyright licence
EndNote style file
Manuscript word template
Guidance for AJA figures
    preparation (in English)

Guidance for AJA figures
    preparation (in Chinese)

Proof-reading for the

AJA Club (in English)
AJA Club (in Chinese)


Societies & Institutes
Databases & Libraries
Other links


Volume 20, Issue 5 (September 2018) 20, 438–441; 10.4103/aja.aja_76_17

Transurethral seminal vesiculoscopy for recurrent hemospermia: experience from 419 cases

Rui Chen1, Lei Wang1, Xia Sheng1, Shu-Guang Piao1, Xin-Wen Nian1, Xin Cheng1, Tie Zhou1, Hui-Zhen Li1, Ya-Wei Liu2, Guang-Hua Chen1, Chun-Lei Zhang1, De-Pei Kong1, Guang-An Xiao1, Xin Lu1, Zhen-Yu Jia1, Zhi-Yong Liu1, Ying-Hao Sun1

1 Department of Urology, Shanghai Changhai Hospital, Second Military Medical University, Shanghai 200433, China
2 Medical College of Chinese People's Liberation Army and Chinese People's Liberation Army General Hospital, Beijing 100853, China

Correspondence: Dr. YH Sun (sunyhsmmu@126.com) or Dr. ZY Liu (medlzhy@aliyun.com)

Date of Submission 22-Mar-2017 Date of Acceptance 11-Jul-2017 Date of Web Publication 27-Apr-2018


We summarized our experience in transurethral seminal vesiculoscopy (TSV) for recurrent hemospermia by introducing surgical techniques, intraoperative findings, and treatment outcomes. TSV was performed in 419 patients with an initial diagnosis of persistent hemospermia at Shanghai Changhai Hospital (Shanghai, China) from May 2007 to November 2015. TSV was successfully performed in 381 cases (90.9%). Hemospermia was alleviated or disappeared in 324 (85.0%) patients by 3 months after surgery. Common intraoperative manifestations were bleeding, obstruction or stenosis, mucosal lesions, and calculus. Endoscopic presentation of the ejaculatory duct orifice and the verumontanum was categorized into four types, including 8 (1.9%), 32 (7.6%), 341 (81.4%), and 38 (9.1%) cases in Types A, B, C, and D, respectively. TSV is an effective and safe procedure in the management of seminal tract disorders. This study may help other surgeons to become familiar with and improve this procedure. However, further multicentric clinical trials are warranted to validate these findings.

Keywords: endoscopy; hemospermia; transurethral seminal vesiculoscopy

Full Text | PDF |

Browse:  306
Copyright 1999-2017  Shanghai Materia Medica, Shanghai Jiao Tong University.  All rights reserved